EGFR and neoplasm: In wtCT26, there was minimal T-cell trafficking or binding to tumor cells, resulting in negligible T-cell mediated cytotoxicity (Fig. 3C) or changes in cell viability (Fig. 3D), as would be expected without EGFR expression.